| Homa Counseling Services Llc | |
|
4676 E Broomfield Rd Mt Pleasant MI 48858-9192 | |
| (989) 301-9729 | |
| Not Available |
| Full Name | Homa Counseling Services Llc |
|---|---|
| Speciality | Social Worker |
| Location | 4676 E Broomfield Rd, Mt Pleasant, Michigan |
| Authorized Official Name and Position | Mary Beth Houpt (CREDENTIALING) |
| Authorized Official Contact | 5176769788 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Homa Counseling Services Llc Po Box 10 Mason MI 48854-0010 Ph: () - | Homa Counseling Services Llc 4676 E Broomfield Rd Mt Pleasant MI 48858-9192 Ph: (989) 301-9729 |
| NPI Number | 1033622089 |
|---|---|
| Provider Enumeration Date | 11/13/2017 |
| Last Update Date | 12/02/2020 |
| Certification Date | 12/02/2020 |
| Medicare PECOS PAC ID | 3577824945 |
|---|---|
| Medicare Enrollment ID | O20180227001554 |
News Archive
James A. Harris, M.D., director of Hair Sciences Center of Colorado, which specializes in state-of-the-art medical and surgical hair restoration, recently introduced to surgeons around the world his latest advancement in hair replacement, the Powered SAFE Scribe. The product was unveiled to the medical community during the 17th Annual Scientific Meeting of the International Society of Hair Restoration Surgery (ISHRS) held in late July in Amsterdam.
A novel research project spearheaded by the University of Leicester and part-funded by The Leverhulme Trust aims to shed new light on the way people perceive art.
Numerous studies have suggested that job loss and unemployment lead to poorer health. Sociologists at the University of Bamberg are now continuing this research and have set out to answer whether job loss still has health-related consequences even if it occurred decades ago and subsequent employment may have been found.
Thomas Jefferson University Hospital is one of a select number of medical centers nationwide—and currently the only one in the Northeast—offering a newly approved optical imaging agent for the detection of papillary cancer of the bladder in patients with known or suspected bladder cancer.
Bayer HealthCare and Onyx Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted priority review designation to Bayer HealthCare's New Drug Application (NDA) filed end of April 2012 for the oral multi-kinase inhibitor regorafenib, for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033622089 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 104100000X | Social Worker | (* (Not Available)) | Primary |
| 1041C0700X | Social Worker - Clinical | 6801080739 (Michigan) | Secondary |
| Provider Name | Michelle M Homa |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1023415320 PECOS PAC ID: 6305160441 Enrollment ID: I20150121001318 |
News Archive
James A. Harris, M.D., director of Hair Sciences Center of Colorado, which specializes in state-of-the-art medical and surgical hair restoration, recently introduced to surgeons around the world his latest advancement in hair replacement, the Powered SAFE Scribe. The product was unveiled to the medical community during the 17th Annual Scientific Meeting of the International Society of Hair Restoration Surgery (ISHRS) held in late July in Amsterdam.
A novel research project spearheaded by the University of Leicester and part-funded by The Leverhulme Trust aims to shed new light on the way people perceive art.
Numerous studies have suggested that job loss and unemployment lead to poorer health. Sociologists at the University of Bamberg are now continuing this research and have set out to answer whether job loss still has health-related consequences even if it occurred decades ago and subsequent employment may have been found.
Thomas Jefferson University Hospital is one of a select number of medical centers nationwide—and currently the only one in the Northeast—offering a newly approved optical imaging agent for the detection of papillary cancer of the bladder in patients with known or suspected bladder cancer.
Bayer HealthCare and Onyx Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted priority review designation to Bayer HealthCare's New Drug Application (NDA) filed end of April 2012 for the oral multi-kinase inhibitor regorafenib, for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.
› Verified 9 days ago
News Archive
James A. Harris, M.D., director of Hair Sciences Center of Colorado, which specializes in state-of-the-art medical and surgical hair restoration, recently introduced to surgeons around the world his latest advancement in hair replacement, the Powered SAFE Scribe. The product was unveiled to the medical community during the 17th Annual Scientific Meeting of the International Society of Hair Restoration Surgery (ISHRS) held in late July in Amsterdam.
A novel research project spearheaded by the University of Leicester and part-funded by The Leverhulme Trust aims to shed new light on the way people perceive art.
Numerous studies have suggested that job loss and unemployment lead to poorer health. Sociologists at the University of Bamberg are now continuing this research and have set out to answer whether job loss still has health-related consequences even if it occurred decades ago and subsequent employment may have been found.
Thomas Jefferson University Hospital is one of a select number of medical centers nationwide—and currently the only one in the Northeast—offering a newly approved optical imaging agent for the detection of papillary cancer of the bladder in patients with known or suspected bladder cancer.
Bayer HealthCare and Onyx Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted priority review designation to Bayer HealthCare's New Drug Application (NDA) filed end of April 2012 for the oral multi-kinase inhibitor regorafenib, for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.
› Verified 9 days ago
Assist & Accelerate Counseling And Consulting Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1503 Batson Dr, Mt Pleasant, MI 48858 Phone: 989-572-0090 | |
Mid-michigan Neurology Center, Pllc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 4595 Jennifer Ln, Mt Pleasant, MI 48858 Phone: 989-772-0453 Fax: 989-773-2538 | |
Ten Sixteen Recovery Network Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1234 E Broomfield St Ste 8, Mt Pleasant, MI 48858 Phone: 989-817-7915 | |
Central Michigan University Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1101 Health Professions Bldg, Ste 2105, Mt Pleasant, MI 48859 Phone: 989-774-3904 Fax: 989-774-1891 | |
Central Michigan Care Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1524 E Broadway St, Mt Pleasant, MI 48858 Phone: 989-854-8334 | |
Counseling Connections Of Central Michigan Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 307 E Michigan St, Mt Pleasant, MI 48858 Phone: 989-772-5833 |